Sklamberg Quoted in Bloomberg Law on the Need to Appoint a Permanent FDA Commissioner
November 10, 2021
Life Sciences & Healthcare Regulatory partner Howard Sklamberg was quoted in a recent article from Bloomberg Law, "Mending Trust on Tap for Next FDA Head as Clock Ticks." Sklamberg commented on the possibility that President Biden may name Former FDA Commissioner Robert Califf to head the agency again. He also touched on the potential impact a new FDA commissioner could have on less expensive alternatives to brand-name biologics and prescription drugs.
» Read the full article (subscription required).